Category: Diagnostic Technologies

Diagnostic Technologies

Researchers Propose Framework for Digital Pathology Adoption

A new study outlines a lifecycle-oriented approach to help laboratories navigate costs, regulatory compliance, and artificial intelligence readiness.

Diagnostic Technologies

New Clinical Guidelines Recommend Molecular Testing for Bladder Cancer

The NCCN has updated its bladder cancer guidelines to include FDA-approved ctDNA-based MRD testing for post-surgical risk assessment and adjuvant immunotherapy decisions in muscle-invasive bladder cancer.

Diagnostic Technologies

Experts Call for End to Routine ‘Corrected’ Calcium Reporting

A new position statement warns that albumin-adjusted calcium formulas are unreliable and may lead to patient misclassification.

Anatomic Pathology

New Imaging Technology Could Speed Up Cancer Diagnosis

Early results indicate the process could reduce sample preparation time by approximately 40% to 50%, while improving consistency by removing variability linked to staining conditions.

Digital Pathology

Proscia Releases New Version of Pathology Platform

The update integrates artificial intelligence into the system architecture to assist with case review, biomarker discovery, and laboratory operations.

Clinical Chemistry

Testosterone Therapy Frequently Prescribed Without Recommended Diagnostic Workup

Research suggests that only 12% of men receiving testosterone prescriptions underwent appropriate testing.

Flow Cytometry

Bio-Rad Expands Antibody Labeling Kits for Flow Cytometry and Western Blot

Bio-Rad has expanded its TrailBlazer StarBright Dye Label Kits to 32 options, now available in Europe for flow cytometry and fluorescent western blot applications, according to the company.

Hematology & Serology

Sysmex America Launches New Hematology Solution for Clinical Labs

The XR-Series features higher throughput and enhanced analytics to streamline daily laboratory operations.

Immunoassay

Seegene Launches New Test for Multidrug-Resistant Organisms in Europe

The assay is CE marked under the European Union In Vitro Diagnostic Regulation and identifies resistance genes to help prevent hospital-acquired infections.

Mass Spectrometry

Bruker Expands Microbiology and Infection Diagnostics Portfolio

New updates include expanded capabilities for microbial identification and advancements in sepsis diagnostics and sequencing workflows.

Microbiology

CirrusDx Adds Lab Testing for Recently Approved UTI Antibiotic

The new capability helps clinicians determine if a patient's infection will respond to gepotidacin before prescribing the treatment.

Molecular Diagnostics

New Guidelines Support CSF Testing for Central Nervous System Cancers

The NCCN has updated its guidelines to recommend cerebrospinal fluid-based molecular profiling for inoperable high-grade gliomas and glioblastomas, expanding indications for liquid biopsy in CNS cancer care.

Point-of-Care

Roche Receives FDA Clearance for Point-of-Care Bordetella Test

The cobas liat system delivers PCR results in 15 minutes, detecting and differentiating between three Bordetella pathogens including whooping cough.

Urinalysis & Toxicology

Urine Metabolite Test Shows Potential for Autism Risk Screening

The screening tool identifies specific molecules produced by gut bacteria to distinguish children with autism from typically developing peers.